Thermo Fisher Scientific Inc. (TMO) PS Ratio: 3.99
Is Thermo Fisher Scientific Inc.’s P/S ratio high or low?
Thermo Fisher Scientific Inc.'s P/S ratio of 3.99 is 20% below its 5-year average of 4.97, near the low end of its 5-year range (3.45–6.78).
The P/S ratio for Thermo Fisher Scientific Inc. (TMO) is 3.99 as of Wednesday, June 10, 2026. It is below its 12-month average by 9.07% (4.39).
TMO PS Ratio Chart
TMO Average PS Ratio Chart
TMO Current vs Average PS Ratio Chart
TMO PS Ratio Metrics
PS RATIO
3.99
PS RATIO AVG TTM
4.39
PS RATIO AVG 3Y
4.67
PS RATIO AVG 5Y
4.97
PS RATIO AVG 10Y
4.75
PS RATIO AVG 15Y
4.05
PS RATIO AVG 20Y
3.64
CURRENT VS TTM AVG
-9.07%
CURRENT VS 3Y AVG
-14.49%
CURRENT VS 5Y AVG
-19.75%
CURRENT VS 10Y AVG
-15.99%
CURRENT VS 15Y AVG
-1.37%
CURRENT VS 20Y AVG
+9.62%
TMO Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | — | 3.99 | 4.39 | 4.67 | 4.97 |
| Amgen Inc. (AMGN) | $183.75B | 4.97 | 4.89 | 5.13 | 5.11 |
| Abbott Laboratories (ABT) | $154.66B | 3.44 | 4.75 | 4.81 | 4.78 |
| Gilead Sciences, Inc. (GILD) | $151.21B | 5.13 | 5.41 | 4.32 | 3.91 |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 14.07 | 18.73 | 19.88 | 19.01 |
| Pfizer Inc. (PFE) | $146.36B | 2.32 | 2.32 | 2.45 | 2.86 |
| Danaher Corporation (DHR) | $130.25B | 5.29 | 6.02 | 6.59 | 6.43 |
| CVS Health Corporation (CVS) | $125.16B | 0.31 | 0.25 | 0.24 | 0.31 |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 2.36 | 2.21 | 2.31 | 2.70 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 9.14 | 9.68 | 10.54 | 9.74 |
P/S vs. its own history
At 3.99, P/S is in its normal range — richer than 60% of its 20-year range.
20-year low
1.21
median
3.50
20-year high
7.42
Sales Valuation
P/S Ratio
3.99
Market Cap / Annual Revenue
Thermo Fisher Scientific Inc. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. PS Ratio FAQ
- What is the P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The P/S ratio for TMO stock is 3.99.
- Is Thermo Fisher Scientific Inc.'s P/S ratio high or low?
- Thermo Fisher Scientific Inc.'s P/S ratio of 3.99 is 20% below its 5-year average of 4.97, near the low end of its 5-year range (3.45–6.78).
- What is the TTM average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average P/S ratio for TMO stock is 4.39.
- What is the 3Y average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average P/S ratio for TMO stock is 4.67.
- What is the 5Y average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average P/S ratio for TMO stock is 4.97.
- What is the 10Y average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average P/S ratio for TMO stock is 4.75.
- What is the 15Y average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average P/S ratio for TMO stock is 4.05.
- What is the 20Y average P/S ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average P/S ratio for TMO stock is 3.64.
Thermo Fisher Scientific Inc. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-10 | 3.99 |
| 2026-06-09 | 4.08 |
| 2026-06-08 | 3.88 |
| 2026-06-05 | 3.90 |
| 2026-06-04 | 3.98 |
| 2026-06-03 | 3.91 |
| 2026-06-02 | 3.98 |
| 2026-06-01 | 4.08 |
| 2026-05-29 | 4.06 |
| 2026-05-28 | 4.02 |
| 2026-05-27 | 3.76 |
| 2026-05-26 | 3.70 |
| 2026-05-22 | 3.70 |
| 2026-05-21 | 3.71 |
| 2026-05-20 | 3.73 |
| 2026-05-19 | 3.70 |
| 2026-05-18 | 3.65 |
| 2026-05-15 | 3.62 |
| 2026-05-14 | 3.70 |
| 2026-05-13 | 3.68 |
| 2026-05-12 | 3.79 |
| 2026-05-11 | 3.74 |
| 2026-05-08 | 3.84 |
| 2026-05-07 | 3.92 |
| 2026-05-06 | 3.90 |
| 2026-05-05 | 3.85 |
| 2026-05-04 | 3.82 |
| 2026-05-01 | 3.87 |
| 2026-04-30 | 4.05 |
| 2026-04-29 | 3.95 |
| 2026-04-28 | 3.98 |
| 2026-04-27 | 3.96 |
| 2026-04-24 | 3.97 |
| 2026-04-23 | 3.95 |
| 2026-04-22 | 4.35 |
| 2026-04-21 | 4.44 |
| 2026-04-20 | 4.45 |
| 2026-04-17 | 4.46 |
| 2026-04-16 | 4.37 |
| 2026-04-15 | 4.50 |
| 2026-04-14 | 4.46 |
| 2026-04-13 | 4.35 |
| 2026-04-10 | 4.20 |
| 2026-04-09 | 4.23 |
| 2026-04-08 | 4.26 |
| 2026-04-07 | 4.14 |
| 2026-04-06 | 4.13 |
| 2026-04-02 | 4.16 |
| 2026-04-01 | 4.18 |
| 2026-03-31 | 4.16 |
| 2026-03-30 | 4.06 |
| 2026-03-27 | 4.01 |
| 2026-03-26 | 4.14 |
| 2026-03-25 | 4.15 |
| 2026-03-24 | 4.15 |
| 2026-03-23 | 4.05 |
| 2026-03-20 | 4.01 |
| 2026-03-19 | 3.98 |
| 2026-03-18 | 3.93 |
| 2026-03-17 | 4.00 |
| 2026-03-16 | 3.98 |
| 2026-03-13 | 3.93 |
| 2026-03-12 | 4.03 |
| 2026-03-11 | 4.19 |
| 2026-03-10 | 4.23 |
| 2026-03-09 | 4.31 |
| 2026-03-06 | 4.25 |
| 2026-03-05 | 4.39 |
| 2026-03-04 | 4.34 |
| 2026-03-03 | 4.30 |
| 2026-03-02 | 4.30 |
| 2026-02-27 | 4.41 |
| 2026-02-26 | 4.40 |
| 2026-02-25 | 4.44 |
| 2026-02-24 | 4.46 |
| 2026-02-23 | 4.46 |
| 2026-02-20 | 4.42 |
| 2026-02-19 | 4.45 |
| 2026-02-18 | 4.44 |
| 2026-02-17 | 4.34 |
| 2026-02-13 | 4.36 |
| 2026-02-12 | 4.41 |
| 2026-02-11 | 4.56 |
| 2026-02-10 | 4.67 |
| 2026-02-09 | 4.73 |
| 2026-02-06 | 4.69 |
| 2026-02-05 | 4.69 |
| 2026-02-04 | 4.89 |
| 2026-02-03 | 4.93 |
| 2026-02-02 | 5.03 |
| 2026-01-30 | 5.00 |
| 2026-01-29 | 5.12 |
| 2026-01-28 | 5.25 |
| 2026-01-27 | 5.39 |
| 2026-01-26 | 5.42 |
| 2026-01-23 | 5.41 |
| 2026-01-22 | 5.53 |
| 2026-01-21 | 5.50 |
| 2026-01-20 | 5.35 |
| 2026-01-16 | 5.35 |
| 2026-01-15 | 5.40 |
| 2026-01-14 | 5.37 |
| 2026-01-13 | 5.25 |
| 2026-01-12 | 5.32 |
| 2026-01-09 | 5.35 |
| 2026-01-08 | 5.24 |
| 2026-01-07 | 5.33 |
| 2026-01-06 | 5.36 |
| 2026-01-05 | 5.28 |
| 2026-01-02 | 5.12 |
| 2025-12-31 | 5.01 |
| 2025-12-30 | 5.04 |
| 2025-12-29 | 5.06 |
| 2025-12-26 | 5.02 |
| 2025-12-24 | 5.01 |
| 2025-12-23 | 5.01 |
| 2025-12-22 | 4.98 |
| 2025-12-19 | 4.91 |
| 2025-12-18 | 4.86 |
| 2025-12-17 | 4.86 |
| 2025-12-16 | 4.93 |
| 2025-12-15 | 4.98 |
| 2025-12-12 | 4.95 |
| 2025-12-11 | 5.00 |
| 2025-12-10 | 4.96 |
| 2025-12-09 | 4.87 |
| 2025-12-08 | 4.91 |
| 2025-12-05 | 4.95 |
| 2025-12-04 | 4.97 |
| 2025-12-03 | 5.02 |
| 2025-12-02 | 5.02 |
| 2025-12-01 | 5.06 |
| 2025-11-28 | 5.11 |
| 2025-11-26 | 5.13 |
| 2025-11-25 | 5.17 |
| 2025-11-24 | 5.07 |
| 2025-11-21 | 5.08 |
| 2025-11-20 | 4.95 |
| 2025-11-19 | 4.96 |
| 2025-11-18 | 4.98 |
| 2025-11-17 | 4.90 |
| 2025-11-14 | 5.00 |
| 2025-11-13 | 5.01 |
| 2025-11-12 | 5.08 |
| 2025-11-11 | 5.07 |
| 2025-11-10 | 4.98 |
| 2025-11-07 | 4.95 |
| 2025-11-06 | 4.89 |
| 2025-11-05 | 4.91 |
| 2025-11-04 | 4.89 |
| 2025-11-03 | 4.88 |
| 2025-10-31 | 4.90 |
| 2025-10-30 | 4.87 |
| 2025-10-29 | 4.88 |
| 2025-10-28 | 4.88 |
| 2025-10-27 | 4.93 |
| 2025-10-24 | 5.01 |
| 2025-10-23 | 5.00 |
| 2025-10-22 | 4.96 |
| 2025-10-21 | 4.88 |
| 2025-10-20 | 4.76 |
| 2025-10-17 | 4.71 |
| 2025-10-16 | 4.70 |
| 2025-10-15 | 4.62 |
| 2025-10-14 | 4.60 |
| 2025-10-13 | 4.59 |
| 2025-10-10 | 4.59 |
| 2025-10-09 | 4.68 |
| 2025-10-08 | 4.69 |
| 2025-10-07 | 4.72 |
| 2025-10-06 | 4.76 |
| 2025-10-03 | 4.75 |
| 2025-10-02 | 4.59 |
| 2025-10-01 | 4.64 |
| 2025-09-30 | 4.24 |
| 2025-09-29 | 4.04 |
| 2025-09-26 | 4.06 |
| 2025-09-25 | 4.02 |
| 2025-09-24 | 4.09 |
| 2025-09-23 | 4.11 |
| 2025-09-22 | 4.16 |
| 2025-09-19 | 4.20 |
| 2025-09-18 | 4.21 |
| 2025-09-17 | 4.13 |
| 2025-09-16 | 4.21 |
| 2025-09-15 | 4.15 |
| 2025-09-12 | 4.19 |
| 2025-09-11 | 4.30 |
| 2025-09-10 | 4.17 |
| 2025-09-09 | 4.22 |
| 2025-09-08 | 4.27 |
| 2025-09-05 | 4.31 |
| 2025-09-04 | 4.28 |
| 2025-09-03 | 4.24 |
| 2025-09-02 | 4.26 |
| 2025-08-29 | 4.31 |
| 2025-08-28 | 4.28 |
| 2025-08-27 | 4.27 |
| 2025-08-26 | 4.27 |
| 2025-08-25 | 4.29 |
| 2025-08-22 | 4.37 |
| 2025-08-21 | 4.23 |
| 2025-08-20 | 4.33 |
| 2025-08-19 | 4.36 |
| 2025-08-18 | 4.26 |
| 2025-08-15 | 4.28 |
| 2025-08-14 | 4.24 |
| 2025-08-13 | 4.24 |
| 2025-08-12 | 4.18 |
| 2025-08-11 | 4.04 |
| 2025-08-08 | 4.03 |
| 2025-08-07 | 3.98 |
| 2025-08-06 | 3.93 |
| 2025-08-05 | 4.08 |
| 2025-08-04 | 4.08 |
| 2025-08-01 | 4.05 |
| 2025-07-31 | 4.13 |
| 2025-07-30 | 4.22 |
| 2025-07-29 | 4.26 |
| 2025-07-28 | 4.28 |
| 2025-07-25 | 4.23 |
| 2025-07-24 | 4.20 |
| 2025-07-23 | 4.12 |
| 2025-07-22 | 3.78 |
| 2025-07-21 | 3.58 |
| 2025-07-18 | 3.66 |
| 2025-07-17 | 3.75 |
| 2025-07-16 | 3.68 |
| 2025-07-15 | 3.69 |
| 2025-07-14 | 3.76 |
| 2025-07-11 | 3.84 |
| 2025-07-10 | 3.81 |
| 2025-07-09 | 3.71 |
| 2025-07-08 | 3.77 |
| 2025-07-07 | 3.70 |
| 2025-07-03 | 3.79 |
| 2025-07-02 | 3.78 |
| 2025-07-01 | 3.72 |
| 2025-06-30 | 3.58 |
| 2025-06-27 | 3.61 |
| 2025-06-26 | 3.64 |
| 2025-06-25 | 3.63 |
| 2025-06-24 | 3.57 |
| 2025-06-23 | 3.54 |
| 2025-06-20 | 3.52 |
| 2025-06-18 | 3.47 |
| 2025-06-17 | 3.45 |
| 2025-06-16 | 3.58 |
| 2025-06-13 | 3.56 |
| 2025-06-12 | 3.67 |
| 2025-06-11 | 3.67 |
| 2025-06-10 | 3.66 |
| 2025-06-09 | 3.61 |
| 2025-06-06 | 3.55 |
| 2025-06-05 | 3.52 |
| 2025-06-04 | 3.57 |
| 2025-06-03 | 3.53 |
| 2025-06-02 | 3.50 |
| 2025-05-30 | 3.56 |
| 2025-05-29 | 3.57 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper